{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:11:41Z","timestamp":1793607101511,"version":"4.5.0"},"reference-count":25,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"unspecified","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,8,6]]},"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Tuberculosis (TB) continues to be one of the deadliest infectious diseases over the centuries, killing more people worldwide than any other single infectious disease. There is an urgent need for additional strategies which can expedite efforts to combat TB including a preventive vaccine. In this endeavour, we have developed a protocol for a multisite, double-blind, placebo-controlled clinical trial in India that aims to evaluate the efficacy and safety of two TB vaccines; namely, VPM1002 and Immuvac (\n                      <jats:italic>M.w<\/jats:italic>\n                      ) (\n                      <jats:italic>Mycobacterium Indicus Pranii<\/jats:italic>\n                      ) (MIP) among healthy household contacts (HHCs) of sputum smear-positive pulmonary TB (PTB) patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      In the three-arm randomised double-blind placebo-controlled trial study protocol, a total of 12\u2009000 HHCs (aged 6\u221299 years) of sputum smear-positive PTB patients will be randomised to receive either of the two vaccine candidates VPM1002 and MIP or placebo. The primary efficacy endpoint is the prevention of microbiologically confirmed TB. Secondary endpoints will include (1) prevention against Latent TB infection, (2) incidence of adverse events and serious adverse events in study participants, (3) efficacy of vaccine in prevention of PTB\/extra PTB in different age groups (6\u201318 years, 19\u201335 years, 36\u201360 years and above 60 years) and (4) immunogenicity of VPM1002 and MIP at month 2 and month 6 after first vaccination in terms of flow cytometric analysis of\n                      <jats:italic>M.Tb<\/jats:italic>\n                      specific CD4+ and\u2009CD8+ T cells secreting cytokines and Luminex assays for the presence of different cytokines in the sera and supernatants of peripheral blood mononuclear cells cultures stimulated with whole cell lysates of\n                      <jats:italic>M.Tb<\/jats:italic>\n                      and subsequently similar analysis for the cases who develop TB postvaccination during the follow-up period.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethics committees\u2019 approvals have been granted by the Institutional Human Ethics Committees of all participating centres in this study and the names of the ethics committees and approvals are as follows: (1) National Institute for Research in Tuberculosis (NIRT)-Chennai (including subsites): ECR\/135\/Inst\/TN\/2013\/RR-19, Approval No. 390\/NIRT-Institutional Ethics Committee (IEC)\/2018 dated 5 December 2018 (NIRT-Madurai-ECR\/1365\/Inst\/TN\/2020; approval dated 8 June 2020; NIRT, Vellore: ECR\/1215\/Inst\/TN\/2019; approval dated 26 September 2020); (2) All India Institute of Medical Sciences (AIIMS), Delhi (including subsites)-Institute Ethics Committee, ECR\/547\/Inst\/DL\/2014\/RR-17 ECR\/538\/Inst\/DL\/2014\/RR-20; approval No.IEC-385\/06-07-2018, approval OP-28\/05.04.2019 and SFH- ECR\/593\/Inst\/DL\/2014\/RR-20 IEC\/VMMC\/SJH\/project\/2019-05\/25 ; 23 May 2019; (3) National Institute of Tuberculosis and Respiratory Diseases (NITRD), Delhi: ECR\/315\/Inst\/DL\/2013\/RR-19; approval IEC-No-NITRD\/EC\/2019\/9004; 8 January 2019; (4) Pune-National AIDS Research Institute (NARI) and subsite-ECR\/23\/Inst\/MH\/2013\/RR-19; IEC-NARI\/EC\/approval\/2018\/196; 29 May 2018; (5) Regional Medical Research Centre-Bhubaneshwar-ECR\/911\/Inst\/OR-2017\/RR-21; approval, dated 25 April 2018; Subsites- AIIMS, Bhubaneshwar ECR\/534\/Inst\/OD\/2014\/RR-17 and 20 approval No. T\/EMF\/Pulm. Med\/19\/01 dated 13 May 2019; SCB, Cuttack No. No.ECR\/84\/Inst\/OR\/2013\/RR-20; approval no.186 dated 7 February 2020; (6) NTI-Bengaluru: Ethics Committee-No-ECR\/1819\/Inst\/KA\/2019; approval No NTI-IEC\/1.2019\/principal investigator, dated 31 January 2019; (7) BMMRC, Hyderabad- ECR\/450\/Inst\/AP\/2013\/RR-16 approval No. 779\/BMMRC\/2018\/IEC, dated 11 June 2018 (Subsite Share India- Mediciti Ethics Committee-ECR\/283\/Inst\/AP\/2013\/RR-20; Approval no. EC\/11\/VII\/2K20(1) dated 11 July 2020) and (8) SJMC-Bengaluru: ECR\/238\/Inst\/KA\/2013\/RR-19; approval IEC\/1\/491\/2020; 7 August 2020.<\/jats:p>\n                    <jats:p>The trial findings will be published in accordance with the Consolidated Standards of Reporting Trials guidance. The results of this clinical trial will be presented at scientific conferences and disseminated through publications in peer-reviewed journals, conference presentations and shared with Ministry of Health and Family Welfare, policy-makers and other stakeholders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>CTRI\/2019\/01\/017026.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-082916","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:25:53Z","timestamp":1733531153000},"page":"e082916","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["PreVenTB trial: protocol for evaluation of efficacy and safety of two vaccines VPM1002 and Immuvac (Mw) in preventing tuberculosis (TB) in healthy household contacts of newly diagnosed sputum smear-positive pulmonary TB patients: phase III, randomised, double-blind, three-arm placebo-controlled trial"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8656-3768","authenticated-orcid":false,"given":"Manjula","family":"Singh","sequence":"first","affiliation":[{"name":"ECD, Indian Council of Medical Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Mehendale","sequence":"additional","affiliation":[{"name":"Clinical Research, Hinduja Hospital, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randeep","family":"Guleria","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, All India Institute of Medical Sciences, New Delhi, India"},{"name":"Medanta The Medicity, Gurgaon, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Sarin","sequence":"additional","affiliation":[{"name":"National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth","family":"Tripathy","sequence":"additional","affiliation":[{"name":"ICMR-National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India"},{"name":"Dr D Y Patil Medical College Hospital and Research Centre, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman R","family":"Gangakhedkar","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Katoch","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra Mohan","family":"Pandey","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research, New Delhi, India"},{"name":"Statistics, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5077-6275","authenticated-orcid":false,"given":"Samiran","family":"Panda","sequence":"additional","affiliation":[{"name":"ECD, Indian Council of Medical Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7717-5592","authenticated-orcid":false,"given":"Sanghamitra","family":"Pati","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research-Regional Medical Research Center, Chandrasekharpur, Bhubaneswar, Orissa, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanta Raghab","family":"Mohapatra","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, All India Institute of Medical Sciences, Bhubaneswar, Orissa, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhu","family":"Joshi","sequence":"additional","affiliation":[{"name":"Bhagwan Mahavir Medical Research Centre (BMMRC), Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somashekar","family":"Narasimhaiah","sequence":"additional","affiliation":[{"name":"National Tuberculosis Institute, Bangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parul","family":"Kodan","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research, New Delhi, India"},{"name":"All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta","family":"Bhaskar","sequence":"additional","affiliation":[{"name":"National Institute of Immunology, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajni","family":"Rani","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research, New Delhi, India"},{"name":"National Institute of Immunology, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Mabood","family":"Khan","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research, New Delhi, India"},{"name":"National JALMA Institute of Leprosy and other Mycobacterial Diseases, Agra, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Swaminathan","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS, World Health Organization, Geneva, Switzerland"},{"name":"MS Swaminathan Research Foundation, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,8,31]]},"reference":[{"key":"2025121510482966000_14.8.e082916.1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S2213-2600(19)30418-7","article-title":"WHO global progress report on tuberculosis elimination","volume":"8","author":"Harding","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025121510482966000_14.8.e082916.2","unstructured":"World Health Organization . Report. Gt global tuberculosis report 2020. Geneva, 2020."},{"key":"2025121510482966000_14.8.e082916.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2016.10.018"},{"key":"2025121510482966000_14.8.e082916.4","doi-asserted-by":"publisher","DOI":"10.1177\/003335490512000309"},{"key":"2025121510482966000_14.8.e082916.5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0970-2113.177445","article-title":"Household symptomatic contact screening of newly diagnosed sputum smears positive tuberculosis patients - An effective case detection tool","volume":"33","author":"Gupta","year":"2016","journal-title":"Lung India"},{"key":"2025121510482966000_14.8.e082916.6","first-page":"S479","article-title":"Yield of casual contact investigation by the hour","volume":"7","author":"Greenaway","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025121510482966000_14.8.e082916.7","first-page":"480","article-title":"Risk factors for clustering of tuberculosis cases: a systematic review of population-based molecular epidemiology studies","volume":"12","author":"Fok","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025121510482966000_14.8.e082916.8","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1016\/j.vaccine.2015.05.088","article-title":"Safety and immunogenicity of candidate vaccine M72\/AS01E in adolescents in a TB endemic setting","volume":"33","author":"Penn-Nicholson","year":"2015","journal-title":"Vaccine (Auckl)"},{"key":"2025121510482966000_14.8.e082916.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70146-3"},{"key":"2025121510482966000_14.8.e082916.10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15761\/JRDM.1000117","article-title":"Vaccination against Tuberculosis: Beyond BCG","volume":"2","author":"Singh","year":"2020","journal-title":"J Respir Dis Med"},{"key":"2025121510482966000_14.8.e082916.11","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.vaccine.2012.12.053","article-title":"Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial","volume":"31","author":"Grode","year":"2013","journal-title":"Vaccine (Auckl)"},{"key":"2025121510482966000_14.8.e082916.12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/CVI.00439-16","article-title":"Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa","volume":"24","author":"Loxton","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"2025121510482966000_14.8.e082916.13","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.905746"},{"key":"2025121510482966000_14.8.e082916.14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.47276\/lr.76.2.127","article-title":"Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years","volume":"76","author":"Sharma","year":"2005","journal-title":"Lepr Rev"},{"key":"2025121510482966000_14.8.e082916.15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0264-410X(91)90309-T","article-title":"Resistance to intravenous inoculation of Mycobacterium tuberculosis H37Rv in mice of different inbred strains following immunization with a leprosy vaccine based on Mycobacterium w","volume":"9","author":"Singh","year":"1991","journal-title":"Vaccine (Auckl)"},{"key":"2025121510482966000_14.8.e082916.16","first-page":"680","article-title":"Improved cure rates in pulmonary tuberculosis category II (retreatment) with mycobacterium w","volume":"101","author":"Patel","year":"2003","journal-title":"J Indian Med Assoc"},{"key":"2025121510482966000_14.8.e082916.17","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5916.90999"},{"key":"2025121510482966000_14.8.e082916.18","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.vaccine.2007.12.025","article-title":"Potential of Mw as a prophylactic vaccine against pulmonary tuberculosis","volume":"26","author":"Katoch","year":"2008","journal-title":"Vaccine (Auckl)"},{"key":"2025121510482966000_14.8.e082916.19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-03514-1","article-title":"Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial","volume":"7","author":"Sharma","year":"2017","journal-title":"Sci Rep"},{"key":"2025121510482966000_14.8.e082916.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039215","article-title":"Efficacy of Mycobacterium indicus pranii immunotherapy as an adjunct to chemotherapy for tuberculosis and underlying immune responses in the lung","volume":"7","author":"Gupta","year":"2012","journal-title":"PLoS One"},{"key":"2025121510482966000_14.8.e082916.21","doi-asserted-by":"crossref","first-page":"6198","DOI":"10.1016\/j.vaccine.2012.07.061","article-title":"Protective efficacy of Mycobacterium indicus pranii against tuberculosis and underlying local lung immune responses in guinea pig model","volume":"30","author":"Gupta","year":"2012","journal-title":"Vaccine (Auckl)"},{"key":"2025121510482966000_14.8.e082916.22","unstructured":"DAIDA, U.S. Department of Health and Human Services, Natiobal Institutes of Health . National institute of allergy and infectious diseases, division of AIDS (DAIDS) table of grading the severity of adult and pedaitric adverse events. 2017. Available: https:\/\/rsc.niaid.nih.gov\/sites\/default\/files\/daidsgradingcorrectedv21.pdf"},{"key":"2025121510482966000_14.8.e082916.23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/2231-4040.191414","article-title":"Interim analysis: A rational approach of decision making in clinical trial","volume":"7","author":"Kumar","year":"2016","journal-title":"J Adv Pharm Technol Res"},{"key":"2025121510482966000_14.8.e082916.24","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2025121510482966000_14.8.e082916.25","unstructured":"The Gazette of India . Available: https:\/\/cdsco.gov.in\/opencms\/export\/sites\/CDSCO_WEB\/Pdf-documents\/NewDrugs_CTRules_2019.pdf"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-082916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T18:48:42Z","timestamp":1765824522000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-082916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,31]]},"published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1136\/bmjopen-2023-082916"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-082916","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]}}}